BioXcel Therapeutics, Inc. Common Stock (BTAI) is a publicly traded Healthcare sector company. As of August 3, 2026, BTAI trades at $0.82 with a market cap of $24.95M and a P/E ratio of -0.18. BTAI moved +0.00% today. Year to date, BTAI is -47.19%; over the trailing twelve months it is -38.32%. Its 52-week range spans $0.74 to $9.26. Rallies surfaces BTAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BTAI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.82 |
| Market Cap | $24.95M |
| P/E Ratio | -0.18 |
| EPS | $-4.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.26 |
| 52-Week Low | $0.74 |
| Volume | 111.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $680.00K |
| Net Income | $-75.33M |
| Gross Margin | 36.32% |
BTAI analyst coverage data. Average price target: $0.00.